Literature DB >> 18271713

Need for cognitive rehabilitation for children with sickle cell disease and strokes.

Allison A King1, Michael R DeBaun, Desiree A White.   

Abstract

Stroke is a significant cause of morbidity among children with sickle cell disease (SCD). Approximately 30% of children with sickle cell anemia will have either an overt stroke or silent infarct (an injury to the brain that does not have any focal neurological findings or a history of focal neurological deficits). Despite the strong association between stroke and cognitive deficits and poor educational attainment, few interventions have been developed to address this vulnerable population of children. A cognitive rehabilitation program was piloted to improve the memory and educational achievement of children with sickle cell disease and stroke. While the intervention was feasible, additional research is needed to establish efficacy. Ongoing studies are designed to improve the cognitive impairment for children with SCD and stroke. The health and educational systems will need to work as partners to improve the cognitive and educational outcomes of these children after they suffer from stroke.

Entities:  

Mesh:

Year:  2008        PMID: 18271713     DOI: 10.1586/14737175.8.2.291

Source DB:  PubMed          Journal:  Expert Rev Neurother        ISSN: 1473-7175            Impact factor:   4.618


  12 in total

Review 1.  Proteomic and biomarker studies and neurological complications of pediatric sickle cell disease.

Authors:  Eboni I Lance; James F Casella; Allen D Everett; Emily Barron-Casella
Journal:  Proteomics Clin Appl       Date:  2014-11-06       Impact factor: 3.494

2.  Higher prevalence of spontaneous cerebral vasculopathy and cerebral infarcts in a mouse model of sickle cell disease.

Authors:  Hyacinth I Hyacinth; Courtney L Sugihara; Thomas L Spencer; David R Archer; Andy Y Shih
Journal:  J Cereb Blood Flow Metab       Date:  2017-09-19       Impact factor: 6.200

3.  Implementation of an educational intervention to optimize self-management and transition readiness in young adults with sickle cell disease.

Authors:  Cecelia L Calhoun; Regina A Abel; Hai Ahn Pham; Shomari Thompson; Allison A King
Journal:  Pediatr Blood Cancer       Date:  2019-03-25       Impact factor: 3.167

4.  Postdischarge pain, functional limitations and impact on caregivers of children with sickle cell disease treated for painful events.

Authors:  Amanda M Brandow; David C Brousseau; Julie A Panepinto
Journal:  Br J Haematol       Date:  2008-12-01       Impact factor: 6.998

5.  Low educational level of head of household, as a proxy for poverty, is associated with severe anaemia among children with sickle cell disease living in a low-resource setting: evidence from the SPRING trial.

Authors:  Halima Bello-Manga; Aisha A Galadanci; Shehu Abdullahi; Shehi Ali; Binta Jibir; Safiya Gambo; Lawal Haliru; Lori C Jordan; Muktar H Aliyu; Mark Rodeghier; Adetola A Kassim; Michael R DeBaun; Najibah A Galadanci
Journal:  Br J Haematol       Date:  2020-05-16       Impact factor: 6.998

6.  COVID-19 and Sickle Cell Disease-Related Deaths Reported in the United States.

Authors:  Amanda B Payne; Laura A Schieve; Karon Abe; Mary Hulihan; W Craig Hooper; Lewis L Hsu
Journal:  Public Health Rep       Date:  2022-01-21       Impact factor: 2.792

7.  Barriers in transition from pediatrics to adult medicine in sickle cell anemia.

Authors:  Jeffrey D Lebensburger; Christina J Bemrich-Stolz; Thomas H Howard
Journal:  J Blood Med       Date:  2012-09-19

Review 8.  A biopsychosocial model for the management of patients with sickle-cell disease transitioning to adult medical care.

Authors:  Lori E Crosby; Charles T Quinn; Karen A Kalinyak
Journal:  Adv Ther       Date:  2015-04-02       Impact factor: 3.845

9.  Role of age and neuroinflammation in the mechanism of cognitive deficits in sickle cell disease.

Authors:  Raven A Hardy; Noor Abi Rached; Jayre A Jones; David R Archer; Hyacinth I Hyacinth
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-22

10.  Pediatric Neurodevelopmental Delays in Children 0 to 5 Years of Age With Sickle Cell Disease: A Systematic Literature Review.

Authors:  La'Kita M J Knight; Allison A King; John J Strouse; Paula Tanabe
Journal:  J Pediatr Hematol Oncol       Date:  2021-04-01       Impact factor: 1.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.